Clinical Trial Update: Safety of Flonoltinib Maleate Tablets for the Treatment of Patients With Myeloproliferative [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports safety findings from Phase 1/2 studies of Flonoltinib Maleate Tablets in patients with myeloproliferative neoplasm and myelof…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Myeloproliferative Neoplasm

Drugs mentioned

• Flonoltinib Maleate Tablets (Flonoltinib maleate)

Snippet

Sponsor: Chengdu Zenitar Biomedical Technology Co., Ltd | Conditions: Myeloproliferative Neoplasm (MPN), Myelofibrosis，MF | Phase 1, Phase 2 | Status: COMPLETED